ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in NVS — Novartis AG

CIK 1165408 Boston, MA

Position in NVS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$39,409,500

+$25,596,581 QoQ

Shares Held

258,000

+157.5% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,579,687,180 across 10 Drug Manufacturers - General names. NVS ranks #9 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	956,817	$880,051,572
2	JNJ	Johnson & Johnson	2,463,008	$602,057,675
3	MRK	Merck & Co., Inc.	2,687,439	$323,272,037
4	ABBV	AbbVie Inc.	1,470,271	$319,769,239
5	GILD	Gilead Sciences, Inc.	916,513	$127,734,416
6	AMGN	Amgen Inc	342,500	$120,508,625
7	BMY	Bristol Myers Squibb Co	1,466,671	$88,953,596
8	BIIB	Biogen Inc.	333,457	$61,132,671

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$39,409,500	258,000	+157.5%	Shares	Sole	2026-05-15
2025-12-31	$13,812,919	100,188	-52.3%	Shares	Sole	2026-02-17
2025-09-30	$26,954,509	210,188	+1351.5%	Shares	Sole	2025-11-14
2025-06-30	$1,752,345	14,481	-95.5%	Shares	Sole	2025-08-14
2024-03-31	$31,296,894	323,549	-18.0%	Shares	Sole	2024-05-15
2023-12-31	$39,829,837	394,472	+26.4%	Shares	Sole	2024-02-14
2023-09-30	$31,777,467	311,972	+30.9%	Shares	Sole	2023-11-14
2023-06-30	$24,057,751	238,408	+80.6%	Shares	Other	2023-08-14
2023-03-31	$12,142,528	131,984	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.